Market share

Interesting info shown in that presentation (yes it’s the same one as before). Existing platform shows burns only a tenth of the market size of vitiligo. One would wonder why they did not go for vitiligo first with ten times the income? One would guess it was because burns are the worst injury of them all therefore success in this would capture the biggest interest and respect amongst the medical professionals (plus the FDA). However looking ahead the new platform has skin rejuvenation at twenty times the market against bullosa and thirty times burns. I would expect on this they put all energy and rescource into rejuvenation, with three approvals given to date, two more approaching very soon, rejuvenation has got to be the big ticket item.